Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

21.04
Delayed Data
As of Feb 05
 -0.83 / -3.80%
Today’s Change
20.54
Today|||52-Week Range
42.48
-25.63%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close21.87
Today’s open21.72
Day’s range20.97 - 22.55
Volume353,071
Average volume (3 months)391,332
Market cap$693.1M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+36.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio81.6
Price/Sales10.36
Price/Book6.17

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...-1.51-7.26%
MACKMerrimack Pharmaceut...-0.37-5.77%
CLLSCellectis SA-1.09-5.07%
NLNKNewLink Genetics Cor...-2.22-8.72%
Data as of 02/05/2016

Financials

Next reporting dateMarch 11, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers